SignalXSignalX

LMAT LEMAITRE VASCULAR INC

8-K Current Report
Filed: February 25, 2026
Health Care
Surgical & Medical Instruments & Apparatus
LEMAITRE VASCULAR INC Overview

LEMAITRE VASCULAR INC (LMAT) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q-period earnings disclosure — full financial results and commentary contained in the referenced press release exhibit (Exhibit 99.1)
  • • LMAT is a vascular surgery device company; earnings reports typically cover revenue, gross margin, and guidance updates material to investors

Get deeper insights on LEMAITRE VASCULAR INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.